Tadalafil Tablet
Product Images NDC 70518-3434

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 70518-3434). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a prescription medication called Tadalafil, in the form of 5 mg tablets, packaged by Ajanta Pharma USA Inc. The medication comes in a bottle containing 100 tablets and should be stored between 20-25°C (68-77°F) with excursions permitted to 15-30°C (53-86°F). The medication should be kept out of the reach of children. Directions for use can be found in the package insert. It was repackaged by RemedyRepack Inc in Indiana.*
FDA Label Image

Mm2 (Tadalafil 5mg 70518 3434 01)

Mm2 (Tadalafil 5mg 70518 3434 01)
Tadalafil is a prescription drug in the form of a tablet with a concentration of 5 mg. The package quantity is one. The medicine contains Rx only and has a National Drug Code of 70518-3434-01. The originating National Drug Code is 27241-0112-05. The manufacturer is Ajanta Pharma USA Inc. located in Bridgewater, NJ. To keep it away from children. The medication instructions are included in the package insert. RemedyRepack Inc based in Indiana, PA 15701 repackaged the medication. The storage temperature for the drug is 20-25°C (83-77°F) as per USP. The temperature can range from 15-30°C (53-86°F).*
FDA Label Image

Tadalafil 5mg 70518 3434 02

Tadalafil 5mg 70518 3434 02
Tadalafil is a medication available in a package of 250 tablets, each containing 5mg. The medication is manufactured by Ajanta Pharma USA Inc. and has an NDC number of 70518-3434-02. The medication should not be split and should be taken as a complete dose. The direction to use the medication is available in the package insert. The medication should be stored at a temperature between 20-25°C (58-77°F), and excursions permitted to 15-30°C (59-86°F). The medication is repackaged by RemedyRepack Inc., Indiana, PA 15701.*
FDA Label Image

Figure8 (Tadalafil Fig8)

Figure8 (Tadalafil Fig8)
This text appears to be a small chart or table related to a study or clinical trial involving the drug Tadalafil and a placebo. The chart shows the IPSS (International Prostate Symptom Score) total score before and after treatment. It also indicates a statistically significant difference between the Tadalafil 5mg group and the placebo group with a p-value of less than 0.01. However, there is no information available about the specific context or purpose of the study, the number of participants or any other details.*
FDA Label Image

Figure1 (Tadalafil Figure1)

FDA Label Image

Figure2 (Tadalafil Figure2)

FDA Label Image

Figure3 (Tadalafil Figure3)

FDA Label Image

Figure4 (Tadalafil Figure4)

FDA Label Image

Figure5 (Tadalafil Figure5)

FDA Label Image

Figure6 (Tadalafil Figure6)

FDA Label Image

Figure7 (Tadalafil Figure7)

FDA Label Image

Structure (Tadalafil Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.